Yüklüyor......
Design and Sample Size Considerations for Alzheimer’s Disease Prevention Trials Using Multistate Models
BACKGROUND/AIMS: Clinical trials for Alzheimer’s disease (AD) have been aimed primarily at persons who have cognitive symptoms at enrollment. However, researchers are now recognizing that the pathophysiological process of AD begins years if not decades prior to the onset of clinical symptoms. Succes...
Kaydedildi:
| Yayımlandı: | Clin Trials |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6442939/ https://ncbi.nlm.nih.gov/pubmed/30922116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774518816323 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|